TherapeuticsMD (TXMD) Change in Cash (2010 - 2026)
TherapeuticsMD (TXMD) posted Change in Cash of $936000.0 for Q1 2026, up 154.35% on a QoQ basis from $368000.0 in Q4 2025, and up 36.44% year-over-year from $686000.0 in Q1 2025.
TherapeuticsMD (TXMD) Change in Cash (2010 - 2026) Analysis & Trends
TherapeuticsMD's Change in Cash history runs 17 years deep, the most recent figure standing at $936000.0 for Q1 2026.
- Quarterly Change in Cash rose 36.44% year-over-year to $936000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (up 90.05% YoY) and the FY2025 annual result came in at $2.4 million, up 231.15% from the prior year.
- Change in Cash was $936000.0 for Q1 2026 at TherapeuticsMD, up from $368000.0 in the prior quarter.
- Across five years, Change in Cash topped out at $12.0 million in Q3 2022 and bottomed at -$34.7 million in Q1 2022.
- A 5-year average of -$3.3 million and a median of $12000.0 in 2024 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash tumbled 160.8% — and 2025, when it jumped 6136.36%.
- TherapeuticsMD's Change in Cash stood at $11.0 million in 2022, then slumped by 153.14% to -$5.8 million in 2023, then surged by 100.21% to $12000.0 in 2024, then surged by 2966.67% to $368000.0 in 2025, then jumped by 154.35% to $936000.0 in 2026.
- Business Quant data shows TXMD's Change in Cash at $936000.0 in Q1 2026, $368000.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - | 936,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 936,000.00 |
| Dec 31, 2025 | 368,000.00 |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 324,000.00 |
| Mar 31, 2025 | 686,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | -185,000.00 |
| Jun 30, 2024 | 894,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | -5.84 Mn |
| Sep 30, 2023 | -3.56 Mn |
| Jun 30, 2023 | -3.52 Mn |
| Mar 31, 2023 | -32.07 Mn |
| Dec 31, 2022 | 10.99 Mn |
| Sep 30, 2022 | 12.03 Mn |
| Jun 30, 2022 | -4.08 Mn |
| Mar 31, 2022 | -34.74 Mn |
| Dec 31, 2021 | -39.72 Mn |
| Sep 30, 2021 | -6.58 Mn |
| Jun 30, 2021 | -26.19 Mn |